about
The impact of outpatient chemotherapy-related adverse events on the quality of life of breast cancer patientsMicrochip-based homogeneous immunoassay using fluorescence polarization spectroscopy.Influence of angiotensin II receptor blocker combination tablet prescription on drug number and cost.The impact of side effects from outpatient chemotherapy on presenteeism in breast cancer patients: a prospective analysis.Study on Students' Impression Data in Practical Training Using Text Mining Method-Analysis of Considerable Communication.Maintenance of Clinical Expertise and Clinical Research by the Clinical Professors at Gifu Pharmaceutical University.Economic evaluation of infection control activities.Hyponatremia and hypokalemia as risk factors for falls.Simultaneous separation, metering, and dilution of plasma from human whole blood in a microfluidic system.Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.Medical and economic factors influencing generic drug use in the Japanese public health system: Influencing factors in different populations.A comparative analysis of micafungin and caspofungin for empirical antifungal therapy in antibiotic-unresponsive febrile patients with hematologic malignancies.An investigation of visual hallucinations associated with voriconazole administration to patients with hematological malignancies.Evaluation of antimicrobial stewardship (AS) for appropriate use of antimicrobial agents.A rapid method to screen poisoning causative agents in an acute care hospital in Japan.A simple method for exploring adverse drug events in patients with different primary diseases using spontaneous reporting system.A New Search Method Using Association Rule Mining for Drug-Drug Interaction Based on Spontaneous Report System.The adoption of generic drugs by a hospital: effects on drug dispensation among community pharmacies.Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database.Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer.Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database.The Effect of Quality of Life on Medication Compliance Among Dialysis Patients.Factors Influencing Medicine Use Behavior in Adolescents in Japan Using a Bayesian Network AnalysisDimer structure of magainin 2 bound to phospholipid vesiclesHeterodimer formation between the antimicrobial peptides magainin 2 and PGLa in lipid bilayers: a cross-linking studyA clinical trial for therapeutic drug monitoring using microchip-based fluorescence polarization immunoassayEconomic evaluation of adjustments of levofloxacin dosage by dispensing pharmacists for patients with renal dysfunction[Effects of the combination of angiotensin receptor blockers and thiazide diuretics on laboratory values (levels of serum potassium, sodium, and uric acid)]Evaluating communication skills after long-term practical training among Japanese pharmacy studentsThe Relationship Between Dialysis Patients' Quality of Life and Caregivers' Quality of LifeCommunity pharmacy-level factors associated with medical and nursing home facility collaboration in JapanImpact of infection control measures on the related costs and the amount of broad-spectrum antimicrobial agents used in a hospital: A time-series analysis[Questionnaire Survey on Collaboration with Medical Facilities/Nursing Home Care Facilities at Community Pharmacies]Factors influencing the use of over-the-counter drugs and health foods/supplementsClinic-level factors associated with collaboration with community pharmacies in JapanReview of Statistical Methodologies for Detecting Drug-Drug Interactions Using Spontaneous Reporting SystemsCost utility analysis of pharmacist counseling care for breast cancer chemotherapy outpatientsAnalysis of Adverse Reactions Caused by Potentially Inappropriate Prescriptions and Related Medical Costs That Are Avoidable Using the Beers Criteria: The Japanese Version and Guidelines for Medical Treatment and Its Safety in the Elderly 2015Association between dipeptidyl peptidase-4 inhibitor and aspiration pneumonia: disproportionality analysis using the spontaneous reporting system in Japan
P50
Q28546730-82DAA7DF-7E73-4851-9964-702CB596A152Q33419169-879BE37D-15F8-47B1-B0E3-28A7DCA4375CQ36462237-7D6D46E0-EBD1-4885-BFDB-8DD4C6885755Q36686014-02570636-73B8-4763-BA5E-6F31804960BAQ38707961-7C63D7EC-EB54-4DDC-9802-452E900F5077Q39042095-8BF3C8C7-27EF-4FC5-BE8E-97E67EB81317Q40201796-6C37C251-0B58-4783-8F9B-4A0BF6DA7ABDQ44227609-2302C47A-1C8C-4581-8EA0-F4908DC74856Q46052363-D6DBFEBF-6CE8-4D08-9628-334EC91B2AB5Q46981976-B26C95D1-B3EA-4058-BE39-54C91274ED3FQ48281893-A32C673B-86CE-45FA-BA44-2ECB27B5BEC5Q50017615-EA623675-FF27-4A38-9DE0-584ECB475ACDQ50018025-4318AD6B-43F8-4A91-9D37-A873634F0C35Q50018699-02943111-2A6B-4627-8137-D29B867254C5Q50647696-29858BC3-EEE1-45CA-BC60-60329E5FF1DDQ52604170-D36A4407-0C07-4A00-B041-0D16241EACDEQ52624670-699DD9F8-D9C3-4F45-B132-7CBE7B055FA0Q53835939-18725C6D-BB00-4B49-ADEA-FDA08DA19D11Q54539709-FAE71CA4-BDF2-4430-9DC8-0E833E68F9F9Q54940160-23A2F5F2-44C0-4F67-8143-1AB9456B7DF5Q55027594-64E0991E-6D94-461D-8335-F6286C75DE0DQ55353198-4D6CF91C-B4CE-40C8-B6AD-6E8F8C30DB4EQ55410791-097E1B90-EE5C-4700-90DE-DB1A190970E1Q64248876-7030CD6A-DBA2-49BC-8214-65DB59A46163Q74479784-229D4795-614C-438A-AF72-57F5FC5F6228Q74601000-60A0B50C-127B-441F-803A-297822BB75FBQ84752605-3C761BBE-16C8-4E07-8FAA-625C2C6FFCD7Q86644139-5188E50C-830E-4C3F-9439-BAB8C3C3FD3BQ87995366-1426EF57-429A-4CCF-8029-FE8358E420EEQ88791560-BB1E1E99-9EDC-42E5-BF21-3E03505EB8A7Q90649891-9688308F-1E63-449A-BCA9-A4A0F3FB3C9FQ91102465-5308A10C-5D4E-4ED5-BCD1-4D2C0CB80E5DQ91136857-C566DB34-7FA9-4AAC-B94E-9C8678F8E23AQ91322663-1B31A493-2591-4E4F-9E8F-F50383CA7964Q91490366-2AE1F3B7-13E0-4740-A081-7E01A5C2A8CBQ91490448-589FD030-BD3E-4B03-958E-216DF587C9B4Q91527660-2FF2FEA4-20BB-4C5D-9D8D-3F59214AD6AAQ91751175-5559FE33-39E2-4CCE-B84F-B9DAAFF91170Q91804659-E07E260D-3B6E-485D-B23C-DD17227FB49FQ91856626-66BA587A-D33D-46CD-98C0-1F006B477E78
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tomoya Tachi
@ast
Tomoya Tachi
@en
Tomoya Tachi
@es
Tomoya Tachi
@nl
type
label
Tomoya Tachi
@ast
Tomoya Tachi
@en
Tomoya Tachi
@es
Tomoya Tachi
@nl
prefLabel
Tomoya Tachi
@ast
Tomoya Tachi
@en
Tomoya Tachi
@es
Tomoya Tachi
@nl
P106
P1153
55620431000
P31
P496
0000-0002-5380-0218